Gilead Whistleblowers May Be Well Placed to Fight DOJ Dismissal

The U.S. Justice Department is expected to try to end a false claims case against Gilead Sciences Inc. as being disruptive to the Food and Drug Administration.

But this is one case that likely won’t end without a fight, and the whistleblowers might have the right arena for it.

Jeffrey and Sherilyn Campie will oppose a DOJ motion to dismiss their fraud-related suit against the drugmaker if and when it is filed, their attorney, Ingrid Evans of The Evans Law Firm, San Francisco, told Bloomberg Law.

The Justice Department’s opposition to such a suit is a death knell for some ...